Vienne A, Collet L, Chevalier T, Borel C, et al. Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (>/= 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study. BMC Cancer 2023;23:663.
PMID: 37452287